Dyadic International, Inc. (DYAI) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good evening, and welcome to Dyadic International's Q1 2026 conference call. Currently, all participants are in a listen-only mode. Following management's prepared remarks, there will be a brief question and answer session. As a reminder, this conference call is being recorded today, May 13th, 2026. I would now like to turn the call over to Ms. Ping Rawson, Dyadic's Chief Financial Officer. Please go ahead. Thank you, operator. Good evening and welcome everyone to DIADC's first quarter 2026 conference call. I hope you have had the opportunity to review DIADC's press releases announcing financial results for the quarter ended March 31st, 2026. You may access our release and form 10-Q and the investor section of the company's website at diadc.com. On today's call, our President and Chief Operating Officer, Joe Hazelton, will review our Q1, 2026 Business and Corporate Highlights and provide commentary on the strategic direction of the business. Our CEO, Mark Edenfarb, will provide an update on our biopharmaceutical programs. And I will follow with a review of our financial results in more detail, after which we will hold a brief Q&A session At this time, I would like to inform you that certain commentary made in this conference call may be considered poor-looking statements, which involve risks and uncertainties and other factors that could cause dietics actual results, performance, scientific or otherwise, or achievements to be materially different from those expressed or implied by these poor-looking statements. Diatics expressly disclaim any duty to provide updates to its poor-looking statements. whether because of new information, future events, or otherwise. Participants are directed to the risk factors set forth in DIAT-X reports filed with the SEC. It is now my p...